I’ve asked the questions in a few different places on here and thought it would be better if all together to show the true picture. I’ve read all of the AAPC articles on the subject of 20610, so I’m familiar with when in diff joint etc, but there’s some confusion on joint and bursa in same general area. I’ve also read multiple threads on here and no absolute answer that I can locate.

Have a Dr billing insurance 20610 x 8 and J1040 x 8, as well as 89051 x4 and 89060 x4.

Here’s a breakdown of one of the scenarios:
Injection/Asp into RT shoulder w/ 45mg of NDC 00009028003
Injection/Asp into LT shoulder w/ 45mg of NDC 00009028003
Injection/Asp into RT subacromial bursa w/ 45mg of NDC 00009028003
Injection/Asp into LT subacromial bursa w/ 45mg of NDC 00009028003
Injection/Asp into RT hip w/ 45mg of NDC 00009028003
Injection/Asp into LT hip w/ 45mg of NDC 00009028003
Injection/Asp into RT trochanteric bursa w/ 45mg of NDC 00009028003
Injection/Asp into LT trochanteric bursa w/ 45mg of NDC 00009028003
Performs synovial fluid analysis for all areas mentioned with wbc provided and no crystals shown.

Questions:
1) Since bursae and shoulder/hip joints are technically different, does the above look correct? Or are they close enough to the joint that you only get the code (20610) once per joint space? CPT wording makes it look like you can get joint AND bursa, so I want to make sure that’s correct.
2) The NDC provided is for J1030, so should it actually be J1030 x9 instead of J1040 x 8?
3) Does 89051 x 4 and 89060 x 4 seem appropriate/accurate if notating wbc’s count and no crystals? (E.G. "LT hip: 5000 wbc and no crystals") Is this notation suffice?

Thank you all SO MUCH for any insight.